908 Devices (MASS) EBIT Margin (2020 - 2026)

908 Devices' (MASS) quarterly EBIT Margin came in at 96.29% in Q1 2026, down 266.0% year-on-year from 58.0% in Q1 2025, and down 641.22% on a QoQ basis from 17.79% in Q4 2025.

908 Devices (MASS) EBIT Margin (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of EBIT Margin data on file, last reported at 96.29% in Q1 2026.

  • On a quarterly basis, EBIT Margin fell 266.0% year-over-year to 96.29% in Q1 2026; TTM through Mar 2026 was 71.41%, a 4530.0% increase from a year earlier, with the FY2025 full-year figure at 70.15%, up 5006.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 96.29%, down from 17.79% in the prior quarter.
  • Over the last five years, EBIT Margin for MASS reached as high as 17.79% in Q4 2025 and fell as low as 168.7% in Q3 2024.
  • Historically, EBIT Margin has averaged 91.2% across 5 years, with a median of 93.62% in 2025.
  • Across the five-year window, EBIT Margin plunged 10513 bps in 2024 and jumped 13457 bps in 2025, its largest moves.
  • Year by year, EBIT Margin stood at 88.79% in 2022, then increased by 24 bps to 67.68% in 2023, then sank by 73 bps to 116.77% in 2024, then jumped by 115 bps to 17.79% in 2025, then plunged by 641 bps to 96.29% in 2026.
  • Per Business Quant data, the three most recent EBIT Margin figures were 96.29% in Q1 2026, 17.79% in Q4 2025, and 116.56% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.05%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 15.55%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 19.10%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 28.97%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 21.42%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.17%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.04%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 908 Devices 261.78 Mn 150.04 Mn 6.88 Mn -96.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 -96.29%
Dec 31, 2025 17.79%
Sep 30, 2025 -116.56%
Jun 30, 2025 -116.31%
Mar 31, 2025 -93.62%
Dec 31, 2024 -116.77%
Sep 30, 2024 -168.70%
Jun 30, 2024 -74.50%
Mar 31, 2024 -102.55%
Dec 31, 2023 -67.68%
Sep 30, 2023 -63.57%
Jun 30, 2023 -90.45%
Mar 31, 2023 -137.21%
Dec 31, 2022 -88.79%
Sep 30, 2022 -45.29%
Jun 30, 2022 -75.36%
Mar 31, 2022 -114.63%
Dec 31, 2021 -22.27%
Sep 30, 2021 -42.06%
Jun 30, 2021 -90.07%